Video

Jubilee Brown on Genetic Counseling for Patients With Breast and Ovarian Cancer

Author(s):

Jubilee Brown, M.D.
Conference|SGO Annual Meeting on Women's Cancer

Jubilee Brown, M.D., obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.

Jubilee Brown, M.D., obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.

Genetic counseling can work as a way of prevention for patients who may be at risk for certain cancers, Brown says.

Related Videos
Image of woman with blonde hair.
Image of woman with blonde hair.
Image of woman with brown hair.
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
a man and a woman in separate boxes in front of a dark blue background
Image of doctor with brown hair.
Image of Doctor with blonde hair.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Related Content
Image of woman with hand on chest.
March 12th 2025

First Patients Enrolled in Trial on Anti-HER2 Therapy in HER2+ Breast Cancer

Spencer Feldman
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ breast cancer using circulating tumor DNA.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
green background with white text indicating FDA Approval, What You Need to Know
March 8th 2025

FDA Approves Biosimilars for Cancer-Related Skeletal Events

Alex Biese
The FDA has approved Stoboclo and Osenvelt to address skeletal issues faced by patients with cancer.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Illustration of a woman with red hair.
March 5th 2025

Becoming a Better Version of Me After Breast Cancer

Bonnie Annis
A revelation has given me perspective for the New Year, inspiring me to embrace change, set new goals and upgrade myself to a better version in 2025.
Image of woman holding pink ribbon.
March 4th 2025

Verzenio Combo May Improve Survival in HR+/HER2– Advanced Breast Cancer

Spencer Feldman
Verzenio plus Faslodex improved progression-free survival in HR+/HER2– advanced breast cancer after CDK/6i failure, with a manageable safety profile.